Study Completed

Bacterial Infection

Bayer Identifier:

Trial_1359

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Ciprofloxacin (sequential IV/PO, Intravenous/Peroral) in pediatric cystic fibrosis patients with acute pulmonary exacerbation

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

5 - 17 Years

Inclusion Criteria
-
Exclusion Criteria
-

Trial summary

Enrollment Goal

Trial Dates

August 1992 - August 1994

Phase

N/A

Could I Receive a placebo

N/A

Products

Cipro IV (Ciprofloxacin, BAYQ3939)

Accepts Healthy Volunteer

N/A

Trial design

Pharmacokinetic determination of ciprofloxacin (sequential IV/PO, Intravenous/Peroral) in pediatric cystic fibrosis patients with acute pulmonary exacerbation

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A